A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M